Artificial Pancreas Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies 2024
April 04, 2024 07:12 ET
|
Research and Markets
Dublin, April 04, 2024 (GLOBE NEWSWIRE) -- The "Artificial Pancreas Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update"...
Artificial Pancreas Device Systems Market: Transforming Diabetes Management and Set to Surpass US$ 1361.5 Million by 2034, Projected Growth Rate of 17.40% – By PMI
February 18, 2024 18:02 ET
|
PMI
Covina, Feb. 18, 2024 (GLOBE NEWSWIRE) -- “According to the recent research study, the Artificial Pancreas Device Systems Market size was valued at about USD 278.1 Million in 2024 and expected to...
Global Artificial Organs Market Research Report 2023-2028: From 3D Bioprinting to Neural Interfaces - New Technologies Paving the Way for Future Growth
August 25, 2023 06:58 ET
|
Research and Markets
Dublin, Aug. 25, 2023 (GLOBE NEWSWIRE) -- The "Artificial Organs: Global Markets" report has been added to ResearchAndMarkets.com's offering. Global Artificial Organs Market is projected to reach...
Artificial Organ Global Market Report 2023: Sector to Reach $31 Billion by 2027 at an 8.7% CAGR
May 19, 2023 08:33 ET
|
Research and Markets
Dublin, May 19, 2023 (GLOBE NEWSWIRE) -- The "Artificial Organ Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global artificial organ market is expected...
Artificial Organs Global Market is Projected to Reach $38.9 Billion by 2030: Increasing Incidence of Cardiovascular Disease Drives the Market for Artificial Heart and VAD
April 24, 2023 12:53 ET
|
Research and Markets
Dublin, April 24, 2023 (GLOBE NEWSWIRE) -- The "Artificial Organs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Artificial...
Diabetes Devices Market to Reach Over USD 90.2 Bn by 2031 with 6.0% of CAGR | TMR Study
April 17, 2023 17:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, April 18, 2023 (GLOBE NEWSWIRE) -- The global diabetes devices market was valued at USD 50.5 Bn in 2021 and is anticipated to reach USD 90.2 Bn by 2031. ...
Artificial Organs Market to hit $30.9 billion by 2025: Global Market Insights, Inc.
November 07, 2019 04:00 ET
|
Global Market Insights, Inc
Selbyville, Delaware, Nov. 07, 2019 (GLOBE NEWSWIRE) -- Global Artificial Organs Market value is expected to cross USD 30.9 billion by 2025, according to a new research report by Global Market...
PharmaCyte Biotech Has Only Scratched the Surface With Its Cell-in-a-Box(R) Technology
August 17, 2015 09:00 ET
|
PharmaCyte Biotech, Inc.
BONITA, CA--(Marketwired - August 17, 2015) - PharmaCyte Biotech Inc. (OTCQB: PMCB) has made a name for itself with the company’s potentially game-changing pancreatic cancer treatment, and also as the...
Xeris Pharmaceuticals Presents Non-Aqueous Glucagon Stability Data at the American Diabetes Association 73nd Scientific Sessions
June 21, 2013 10:00 ET
|
Xeris Pharmaceuticals, Inc.
Austin, TX, June 21, 2013 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. ("Xeris") announces today that it is
presenting at the American Diabetes Association 73nd Scientific
Sessions in Chicago, IL...
Xeris Pharmaceuticals Awarded Phase II Funding of NIH Fast -Track SBIR Grant to Advance Glucagon for the Artificial Pancreas
April 17, 2013 11:39 ET
|
Xeris Pharmaceuticals, Inc.
Austin, TX, April 17, 2013 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. ("Xeris"), an Austin-based,
pharmaceutical company developing patient-friendly injectable
treatments for diabetes and other...